GlucoTrack surges as traders revisit Lōkahi merger and new financing package

GlucoTrack Inc. (GCTK) is up 190.0% today. Here is some analysis on what might have caused this price movement.

Analysis: A clear same-day corporate announcement was not easy to find, so the move appears most likely tied to renewed interest in GlucoTrack’s recently completed business combination with Lōkahi Therapeutics and the financing package announced around that deal. This could also be because the stock was trading from a very low base, which can amplify momentum and speculative buying in small-cap names.

Details:

On July 14, GlucoTrack closed its merger with Lōkahi Therapeutics, making Lōkahi a wholly owned subsidiary and giving former Lōkahi holders the right to own most of the combined company on a fully diluted basis after conversion approvals.

The same 8-K outlined roughly $4.45 million of bridge financing and a common stock purchase agreement that could provide up to $50 million over time, giving traders a fresh capital-markets narrative to focus on.

Company materials described the combined platform as pairing Lōkahi’s therapeutic asset development model with GlucoTrack’s diabetes technology business, which may have broadened the story beyond the legacy glucose-monitoring program alone.

Recent company disclosures also highlighted a new patent allowance tied to the implantable continuous blood glucose monitoring platform and a proxy proposal for a 1-for-30 reverse split as GlucoTrack works to address listing compliance issues.

Sources:

SEC, GlucoTrack, GlobeNewswire

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$GCTK Hedge Fund Activity

We have seen 8 institutional investors add shares of $GCTK stock to their portfolio, and 1 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

GEODE CAPITAL MANAGEMENT, LLC added 47,001 shares (+inf%) to their portfolio in Q1 2026, for an estimated $30,550
HRT FINANCIAL LP added 40,631 shares (+inf%) to their portfolio in Q1 2026, for an estimated $26,410
GRANITE ISLANDS PRIVATE WEALTH, LLC added 15,700 shares (+inf%) to their portfolio in Q2 2026, for an estimated $5,008
TOWER RESEARCH CAPITAL LLC (TRC) added 3,017 shares (+709.9%) to their portfolio in Q1 2026, for an estimated $1,961
UBS GROUP AG added 583 shares (+489.9%) to their portfolio in Q1 2026, for an estimated $378
TRADEWINDS CAPITAL MANAGEMENT, LLC added 50 shares (+inf%) to their portfolio in Q2 2026, for an estimated $15
BANK OF AMERICA CORP /DE/ removed 28 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $18

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.